Skip to content

FRAPEJA PHARMA

Active
Private limited companyfounded 2014active for 12 yearsMeulesteedsesteenweg 7, 9000 Gent, BelgiumKBO/BCE: BE 0562.774.303

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
05-06
NBB filing Annual accounts 2025 filedPDF
abbreviated format · 56 days before the deadline
2025
26-05
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 66 days before the deadline
2024
05-11
Gazette deed Resignation: APRIVO BV (director)
Appointment: Frapeja Invest (director) · Permanent representative: Van Gansbeke Steven · Director discharge5 points ▸
  • General meeting, 23-09-2024
  • Director resignation, APRIVO BV (director)
  • Director discharge, APRIVO BV
  • Director appointment, Frapeja Invest (director)
  • Permanent representative, Van Gansbeke Steven

Open the act in the Belgian Official Gazette

17-07
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 14 days before the deadline
2023
31-12
Financial Highest result from 2018 to 2025net €111,137 ▲13.2%
The operating result of €125,580 and the net result of €111,137 are both a record.
31-12
Financial Equity above €150,000equity €176,651 ▲170%
After 2 profitable years in a row, equity reaches €176,651.
17-10
Gazette deed Registered office moved from Lievegem to Gent
2 points ▸
  • Board meeting, 01-10-2023
  • Registered-office move, 9000 Gent, Meulesteedsesteenweg 7

Open the act in the Belgian Official Gazette

05-04
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 117 days before the deadline
2022
31-12
Financial Back to profitnet €98,142
The net result is €98,142, after 3 loss-making years.
06-09
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 37 days late
2021
05-05
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 87 days before the deadline
2020
07-07
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 24 days before the deadline
Show earlier events
2019
31-12
Financial Weakest financial yearnet -€256,121
The net result drops to -€256,121, the lowest from 2018 to 2025. It recovers the following year.
03-07
NBB filing Annual accounts 2018 filedPDF
abbreviated format · 28 days before the deadline
2018
21-06
NBB filing Annual accounts 2017 filedPDF
abbreviated format · 40 days before the deadline
2017
28-08
NBB filing Annual accounts 2016 filedPDF
abbreviated format · 28 days late
2014
22-09
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

FRAPEJA PHARMA was incorporated on 18 September 2014.1 The registered office was moved to Gent in 2023.2 Total assets rose from €326,857 in 2018 to €772,946 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 17-10-2023
  3. 3National Bank, annual accounts 2018 and 2025

Next steps